Skip to Main Content

Paper Details

Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancer.
JCI Insight
41
2017
Cancer, EGFR, HNSCC, Patients, STAT3, Src, Src family kinases, dasatinib, erlotinib, head and neck cancer, head and neck squamous cell carcinoma, pMAPK, pSTAT3, pSrc, patients, tissue microarrays, tumor
Author NameAffiliation
Julie E Bauman
Umamaheswar DuvvuriUniversity of Pittsburgh
Antonio JimenoDivision of Medical Oncology University of Colorado
Wendell G YarbroughVanderbilt University
Wendell G YarbroughVanderbilt University
Simion I ChioseaUniversity of Pittsburgh
Gordon B MillsMD Anderson Cancer Center
Gordon B MillsMD Anderson Cancer Center
Jennifer R GrandisUniversity of Pittsburgh
Jennifer R GrandisUniversity of Pittsburgh
  • 1 - 10

Datasets

Release 1.2